# Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets.

> **NCT00713791** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 20 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ZD4054
- **DRUG:** ZD4054
- **DRUG:** ZD4054
- **DRUG:** ZD4054

## Key facts

- **NCT ID:** NCT00713791
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** —
- **Final completion:** 2008-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00713791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00713791, "Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00713791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*